The company
Immunic, Inc.
IMUX · Nasdaq
IMUX stood above a rising 150-day average in 27 of the last 52 weekly readings, and has been out of that trend for the last 6 weeks. It is 44.0% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 6
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 55 (-18)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 27 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Aberdeen Group plcreduced · filed 31 Jul 2026 | 824,393$12.7M | -7,419,548−90.0% |
| BVF INCreduced · filed 14 Aug 2026 | 765,295$11.8M | -6,887,677−90.0% |
| MILLENNIUM MANAGEMENT LLCreduced · filed 14 Aug 2026 | 740,347$11.4M | -3,039,575−80.4% |
| Avidity Partners Management LPunchanged · filed 14 Aug 2026 | 669,941$10.3M | 00.0% |
| BRAIDWELL LPnew · filed 14 Aug 2026 | 645,010$9.9M | +645,010 |
| Laurion Capital Management LPreduced · filed 13 Aug 2026 | 610,326$9.4M | -3,271,836−84.3% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 571,561$8.8M | -4,566,755−88.9% |
| Jones Hill Capital LPnew · filed 13 Aug 2026 | 539,814$8.3M | +539,814 |
| Woodline Partners LPreduced · filed 14 Aug 2026 | 471,528$7.2M | -495,624−51.2% |
| Soleus Capital Management, L.P.reduced · filed 11 Aug 2026 | 450,000$6.9M | -4,050,000−90.0% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.